article thumbnail

Babies born to women consuming a high fat, sugary diet at greater risk of cardiovascular disease and diabetes in later life

Science Daily - Heart Disease

Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.

Diet 132
article thumbnail

Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients

Med Page Today

(MedPage Today) -- An anti-inflammatory diet was tied to a lower risk for dementia in people ages 60 and older with cardiometabolic diseases, U.K. Among people with cardiometabolic diseases including type 2 diabetes, heart. Biobank data showed.

Diet 136
article thumbnail

The Case for Keto for Type 1 Diabetes with Andrew Koutnik, Ph.D.

Physiologically Speaking

Andrew is a research scientist at Sansum Diabetes Research Institute, where he’s investigating metabolic therapies for health and disease. His mission is to optimize metabolic health and patient outcomes for people living with type 1 diabetes. Andrew is unique because he himself has type 1 diabetes.

Diabetes 115
article thumbnail

How CTVS Treats Diabetes Complications

CTVS

Diabetes affects millions of Americans. If managed well through proper diet and medication, those with diabetes can lead full and active lives. There are however some serious complications commonly associated with diabetes, like cardiovascular disease, kidney disease, and PAD (Peripheral Artery Disease).

article thumbnail

First Generic of Once-Daily GLP-1 Injection Approved for Diabetes

Med Page Today

(MedPage Today) -- The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to diet and exercise.

article thumbnail

Poor Sleep Habits Tied to Diabetes Risk, Even with Healthy Dietary Habits

HCPLive

Results of a new analysis underscore the significance of sleep health in mitigating type 2 diabetes risk, revealing that even an optimal diet may not fully offset the negative impact of inadequate sleep.

Diabetes 105
article thumbnail

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes

Cardiovascular Diabetology

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. Conclusions The findings suggest that fenofibrate may be a useful therapeutic agent for obesity- and diabetes-related cardiomyopathy.

Obesity 98